Latest Stories
FreeGuest Editorial
It was a thrilling moment for me when, sitting on my living room couch, listening to the State of the Union address, I heard the president say:
FreeGuest Editorial
This month, I should be taking my son, Jacob, to college. Instead, I'm participating in Curefest for Childhood Cancer on the Mall here in D.C.
FreeGuest Editorial
Kudos to The Cancer Letter's report on the 803 PD-1 or PD-L1 trials. As Rick Pazdur noted, that is just too many resources chasing the same idea for adult cancer studies.
FreeGuest Editorial
Emma Whitehead was a six-year-old girl battling relapsed leukemia for the third time when her parents were told she had run out of treatments. Her doctors offered one last hope—enrollment in a clinical trial at Children's Hospital of Philadelphia in a completely new immunotherapy. It was a phase I toxicity trial for both children and adult patients, and few patients on phase I trials are ever cured. But Emma's family was given the miracle they had prayed for. Five years later, Emma is now a happy, healthy, 11-year-old girl who likes to play piano and soccer. Emma is cured.
